Marisela Madrigal, MD
Pediatrics · Morgan Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Madrigal’s office at (408) 720-6670 to ask if they take your plan before you enroll.
California Medical Board record
Licence A179385 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$882,300 in 2024
Medicaid paid $882,300 for 12,215 billed services this clinician did in 2024, up to 244 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,699 | $877,356 |
| Developmental screening | 243 | $2,745 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 600 | $808 |
| Return visit (30+ min) | 837 | $410 |
| Short return visit (20+ min) | 674 | $262 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 446 | $173 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 500 | $121 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 406 | $109 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 153 | $103 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 551 | $68 |
| Measurement of lead | 45 | $64 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 266 | $33 |
| 2024 | 12,215 | 28 | 244 | $882,300 |
| 2023 | 8,915 | 28 | 232 | $1,078,754 |
| 2022 | 1,695 | 18 | 257 | $267,493 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 2,141 | $1,076,340 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 534 | $710 |
| Developmental screening | 77 | $300 |
| Short return visit | 1,107 | $220 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 443 | $218 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 213 | $161 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 14 | $143 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 365 | $125 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 361 | $99 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 340 | $82 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 112 | $63 |
| Screening test, pure tone, air only | 146 | $52 |
2022
| Clinic visit/encounter, all-inclusive | 538 | $266,663 |
| Short return visit | 470 | $325 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 20 | $314 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 41 | $190 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 13 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 56 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 54 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 13 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 24 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 19 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 100 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 23 | $0 |
Professional record
- NPI
- 1962065169
- Licence
- CA A179385California A179385: Current · expires 2028-08-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2019-04-15
- NPI last updated
- 2025-06-03
- NPI record certified
- 2025-06-03
This is when the NPI record was last certified, not a medical board exam.